The forecasted import volume of penicillins or streptomycins in dosage forms to the UK is projected to decrease consistently from 2.9169 million kilograms in 2024 to 2.8363 million kilograms by 2028. Compared to 2023, where the actual data was available, this represents a gradual yet steady decline in import volumes.
Year-on-year percentage changes indicate a slight decrease each year, highlighting a consistent downward trend. The compound annual growth rate (CAGR) over the five years suggests an average annual reduction in imports.
Looking forward, potential future trends to monitor include shifts in international regulations affecting drug imports, changes in local manufacturing capabilities, and variations in demand for these antibiotics due to public health initiatives or emerging resistance patterns.
